FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  S. M. Toor,et al.  Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment , 2017, Oncotarget.

[3]  Ronald D. Vale,et al.  T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition , 2016, Science.

[4]  Xuehao Wang,et al.  Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions , 2016, Cellular &Molecular Immunology.

[5]  J. C. Love,et al.  PD-1 marks dysfunctional regulatory T cells in malignant gliomas. , 2016, JCI insight.

[6]  W. Liu,et al.  TCR usage, gene expression and function of two distinct FOXP3+Treg subsets within CD4+CD25hi T cells identified by expression of CD39 and CD45RO , 2016, Immunology and cell biology.

[7]  Bin Shang,et al.  Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis , 2015, Scientific Reports.

[8]  J. Tegnér,et al.  IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3 , 2015, Scientific Reports.

[9]  V. De Rosa,et al.  Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants , 2015, Nature Immunology.

[10]  K. Schmierer,et al.  Is it time to target no evident disease activity (NEDA) in multiple sclerosis? , 2015, Multiple sclerosis and related disorders.

[11]  V. Sharma,et al.  Alteration in regulatory T cells and programmed cell death 1‐expressing regulatory T cells in active generalized vitiligo and their clinical correlation , 2015, The British journal of dermatology.

[12]  E. Volpe,et al.  CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes. , 2014, Immunology letters.

[13]  K. Lynch,et al.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn , 2013, Immunological reviews.

[14]  C. Hsieh,et al.  Selection of regulatory T cells in the thymus , 2012, Nature Reviews Immunology.

[15]  J. Buckner.  Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases , 2010, Nature Reviews Immunology.

[16]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[17]  S. Sakaguchi,et al.  Regulatory T cells: roles of T cell receptor for their development and function , 2010, Seminars in Immunopathology.

[18]  N. Tubridy,et al.  CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1 , 2009, The Journal of Immunology.

[19]  T. Nomura,et al.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.

[20]  Laura Conti,et al.  T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β , 2009, Annals of neurology.

[21]  M. Kleinewietfeld,et al.  CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. , 2009, Blood.

[22]  V. Kuchroo,et al.  Induction and effector functions of TH17 cells , 2008, Nature.

[23]  Yong‐jun Liu,et al.  Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. , 2008, Immunity.

[24]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[25]  S. Ziegler,et al.  Isoform-Specific Inhibition of RORα-Mediated Transcriptional Activation by Human FOXP31 , 2008, The Journal of Immunology.

[26]  K. Venken,et al.  Compromised CD4+ CD25high regulatory T‐cell function in patients with relapsing‐remitting multiple sclerosis is correlated with a reduced frequency of FOXP3‐positive cells and reduced FOXP3 expression at the single‐cell level , 2008, Immunology.

[27]  P. Rossini,et al.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.

[28]  H. Wiendl,et al.  Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients , 2007, Clinical and experimental immunology.

[29]  Emma L. Smith,et al.  Splice variants of human FOXP3 are functional inhibitors of human CD4+ T‐cell activation , 2006, Immunology.

[30]  S. Ziegler,et al.  Analysis of FOXP3 Reveals Multiple Domains Required for Its Function as a Transcriptional Repressor1 , 2006, The Journal of Immunology.

[31]  H. Broxmeyer,et al.  Regulation of Trafficking Receptor Expression in Human Forkhead Box P3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[32]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[33]  W. Selby,et al.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.

[34]  S. Ziegler,et al.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. , 2005, The Journal of clinical investigation.

[35]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[36]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[37]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[38]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[39]  G. Freeman,et al.  CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.

[40]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[41]  Nitin J. Karandikar,et al.  Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. , 2008, Blood.

[42]  S. Ziegler,et al.  Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. , 2008, Journal of immunology.

[43]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[44]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[45]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[46]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.